Neuroscience Clinical Trials Unit

Image used under license from

We help facilitate clinical research across the Division of Clinical Neuroscience at Oslo University Hospital (OUH). OUH is the largest hospital in the Nordics and the division delivers over 60 000 outpatient visits per year, attending to more than half of the Norwegian population affected by neurological ailments. We conduct studies on conditions such as Amyotrophic Lateral Sclerosis (ALS), Cognitive Impairment, Epilepsy, Headache and Migraine, Huntington’s Disease and Neurogenetic Disorders, Multiple Sclerosis (MS), Pain, Parkinson’s Disease, Rare Neuromuscular Disorders (NMD), Sleep Disorders and Stroke. To read more about ongoing projects, please see the tab in the menu on the left side of the page.

The aim of the Neuroscience Clinical Trials Unit (NCTU) is to promote brain health through research support services. The unit consists of a team of trained research staff, including study coordinators and study nurses, and is led by the Head of Research at the Division of Clinical Neuroscience, John-Anker Zwart. The team works in close collaboration with project leaders across the departments in the division and assists with the organization of clinical studies, and the treatment and follow-up of participants taking part in clinical trials.

The NCTU also runs a clinical trials committee that meets biweekly to evaluate study requests from the medical industry, as well as from academic organizations. In line with Norway’s Brain Health Strategy and Action Plan for Clinical Studies, the committee works to contribute to increase the number of clinical studies conducted within this important research field in Norway.

If you are looking to collaborate or want to get in touch with a local principal investigator (PI), please do not hesitate to contact us. All requests can be sent to the following NCTU email address:

A printer friendly presentation of the NCTU can also be found here: Neuroscience Clinical Trials Unit - Oslo, Norway

Last updated: June 25, 2021